Cargando…
Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies. Gemcitabine is the most commonly used chemotherapy for the treatment of PDAC, but the development of drug resistance still remains challenging. Recently, exosomes have emerged as important mediators for intercellular commu...
Autores principales: | Li, Xinyuan, Li, Kai, Li, Mengmeng, Lin, Xiaoyu, Mei, Yu, Huang, Xuemei, Yang, Huanjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865617/ https://www.ncbi.nlm.nih.gov/pubmed/35223528 http://dx.doi.org/10.3389/fonc.2022.844648 |
Ejemplares similares
-
Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer
por: Fan, Jia, et al.
Publicado: (2018) -
miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer
por: Mei, Yu, et al.
Publicado: (2021) -
lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCF(β-TRCP)-Mediated Degradation of NRF2 in Pancreatic Cancer
por: Yang, Qingzhu, et al.
Publicado: (2020) -
RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
por: Si, Wentao, et al.
Publicado: (2022) -
Exosomes and their roles in the chemoresistance of pancreatic cancer
por: Pan, Yubin, et al.
Publicado: (2022)